Literature DB >> 12351213

Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (complex I) in rat heart.

Elena Maklashina1, Yelizaveta Sher, Hui-Zhong Zhou, Mary O Gray, Joel S Karliner, Gary Cecchini.   

Abstract

The multi-subunit mammalian NADH-ubiquinone oxidoreductase (complex I) is part of the mitochondrial electron transport chain and physiologically serves to reduce ubiquinone with NADH as the electron donor. The three-dimensional structure of this enzyme complex remains to be elucidated and also little is known about the physiological regulation of complex I. The enzyme complex in vitro is known to exist as a mixture of active (A) and de-active (D) forms [Biochim. Biophys. Acta 1364 (1998) 169]. Studies are reported here examining the effect of anoxia and reperfusion on the A/D-equilibrium of complex I in rat hearts ex vivo. Complex I from the freshly isolated rat heart or after prolonged (1 h) normoxic perfusion exists in almost fully active form (87+/-2%). Either 30 min of nitrogen perfusion or global ischemia decreases the portion of active form of complex I to 40+/-2%. Upon re-oxygenation of cardiac tissue, complex I is converted back predominantly to the active form (80-85%). Abrupt alternation of anoxic and normoxic perfusion allows cycling between the two states of the enzyme. The possible role in the physiological regulation of complex I activity is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351213     DOI: 10.1016/s0005-2728(02)00280-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  Isolation and transcription profiling of low-O2 stress-associated cDNA clones from the flooding-stress-tolerant FR13A rice genotype.

Authors:  Sangeeta Agarwal; Anil Grover
Journal:  Ann Bot       Date:  2005-08-22       Impact factor: 4.357

2.  Allosteric nucleotide-binding site in the mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I).

Authors:  Vera G Grivennikova; Grigory V Gladyshev; Andrei D Vinogradov
Journal:  FEBS Lett       Date:  2011-05-27       Impact factor: 4.124

Review 3.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

4.  Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.

Authors:  Maria Chomova; Maria Balazova; Jana Muchova
Journal:  Mol Cell Biochem       Date:  2017-05-19       Impact factor: 3.396

Review 5.  An update on the role of mitochondrial α-ketoglutarate dehydrogenase in oxidative stress.

Authors:  Anatoly A Starkov
Journal:  Mol Cell Neurosci       Date:  2012-07-20       Impact factor: 4.314

6.  Biphasic modulation of the mitochondrial electron transport chain in myocardial ischemia and reperfusion.

Authors:  Hsin-Ling Lee; Chwen-Lih Chen; Steve T Yeh; Jay L Zweier; Yeong-Renn Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

7.  Ischemia-induced inhibition of mitochondrial complex I in rat brain: effect of permeabilization method and electron acceptor.

Authors:  Maria Chomova; Zuzana Tatarkova; Dusan Dobrota; Peter Racay
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

8.  Inhibitory effect of palmitate on the mitochondrial NADH:ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition.

Authors:  Maria V Loskovich; Vera G Grivennikova; Gary Cecchini; Andrei D Vinogradov
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

Review 9.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

10.  Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.

Authors:  Robert M Mentzer; Joseph Wider; Cynthia N Perry; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-12-23       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.